Working with Tubing for Peristaltic Pumps - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Working with Tubing for Peristaltic Pumps
Thermoplastic elastomer tubing can be used for an entire line, including through the peristaltic pump.

Equipment and Processing Report

Untitled Document

Q. My application involves a peristaltic pump with silicone tubing running through it and a different, heat-sealable tubing material before and after the pump section. Recently, an operator installed the wrong section of tubing in a pump, resulting in lost API, equipment replacement, and hours of extra work. How can we avoid this kind of mix-up in the future?

A. One solution is to label different tubing sections for their intended use. Another approach is to use one tubing material, namely a thermoplastic elastomer (TPE), for the entire line. TPE is often used before and after the pump section where sealability is needed. TPE properties vary depending on the formulation and the process used to make the polymer, and in the past some formulations could not be used inside the pump. Today, however, there are versions of TPE that work very well in peristaltic pumps and can be used for the entire line. 

A possible concern is using steam sterilization with TPE because steam tends to deform tubing.  Some steam cycles can be used as long as they have a lower temperature and time exposure cycle and care is taken in positioning the tubing in the autoclave. A user who intends to sterilize with steam should validate their sterilization cycle with the intended use of a TPE tubing. Gamma radiation sterilization poses no problems with either silicone or TPE.

Using a single tubing eliminates fitting connections and tie wraps, along with their possible leaks and entrapment issues. Having a single material also simplifies the overall design, reduces inventory expenses, shortens assembly time and labor, and eliminates the possibility of installing the wrong tubing section in the pump.

—John Stover, product technical director, New Age Industries.

If you have a problem with your equipment or process, an industry expert may have the solution. Please send your question to Jennifer Markarian, editor of Equipment and Processing Report, and we may be able to provide an answer in a future issue. All questions will remain anonymous.

 

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Source: Equipment and Processing Report,
Click here